New paediatric HIV/AIDS centre for Swaziland
This article was originally published in Clinica
Swaziland's first medical centre dedicated to paediatric HIV/AIDS care is being built in Mbabane. Construction of the centre began officially last week, in a high-profile event attended by Prime Minister Absalom Themba Dlamini and health minister Chief Sipho Shongwe. It is due to open in December 2005. The centre is being funded under Bristol-Myers Squibb's $120m Secure the Future programme, which was established with the aim of supporting HIV care of women and children in sub-Saharan Africa, where there is an estimated 1.9 million HIV-infected under-15s.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.